Project Grant W81XWH2210765

This Project Grant award of $353,391.00, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate the use of a "Personal Learning Curve" paradigm as a sensitive marker of early memory decline related to Alzheimer's disease (AD) biomarkers in a large, diverse sample of older adults. The study seeks to determine if this digital cognitive assessment tool, which measures learning over repeated evaluations, can detect subtle AD-related memory failures...

CONNECT: Diagnostic Disclosure Communication Intervention in Dementia Care The National Institute on Aging (NIA) awarded a Project Grant of $197,555 to Massachusetts General Hospital (The General Hospital Corporation) effective July 1, 2026, through June 30, 2031, under the Aging Research program (CFDA 93.866). This award supports the development and optimization of CONNECT (Collaborative Navigation and Nurturing Empathy Through Communication Techniques), a structured diagnostic disclosure...

Summary The National Institute on Aging awarded a Project Grant of $722,746 to Massachusetts General Hospital (effective February 15, 2026, with completion by January 31, 2031) under the Aging Research program (CFDA 93.866) to conduct a multi-site clinical trial of the Coma Family Program (COMA-F), a resilience intervention designed to address emotional distress among caregivers of patients with severe acute brain injury (SABI). The primary deliverable is evidence-based testing of COMA-F's...

Project Grant Award Summary Yale University received a $242,902 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866) beginning September 9, 2025, with completion targeted for May 31, 2030. The award supports the development and pilot testing of CAPTURE (Care Partner Text Message Intervention to Improve Future Outcomes), an automated text messaging intervention designed to improve emergency department (ED) care transitions for informal care...

This Project Grant award of $4,787,820.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a better understanding of the individual- and system-level characteristics that influence diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), and how diagnosis can moderate the effects of cognitive decline on employment, future care, and quality of life. The key objectives are to: 1) examine whether older adults experiencing...

COMTAD Project Grant Summary The University of Kansas Medical Center Research Institute, Inc. received a $589,614 Project Grant award from the National Institute on Aging (Aging Research, CFDA 93.866) effective February 1, 2026, through December 31, 2030, to develop and validate a cognitive safety monitoring system for detecting adverse side effects of anti-amyloid therapy in Alzheimer's disease treatment. The Cognitive Monitoring During Treatment for Alzheimer Disease (COMTAD) study will...

This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $2,373,964 will fund a 3-year study examining the use of telehealth to improve care for long-stay nursing home residents with Alzheimer's disease and related dementias (ADRD). The key objectives are to: 1) qualitatively assess how telehealth is used in nursing homes and barriers/facilitators to its adoption, 2) characterize telehealth and in-person care utilization patterns for this population...

Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Washington a Project Grant of $756,062 on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242). The grant funds a randomized controlled trial (RCT) testing the effectiveness of VOCALE LBD, a fully asynchronous, low-bandwidth, text-based psychoeducational online intervention specifically tailored for family caregivers of persons living with Lewy body dementia (LBD). The...

The National Institutes of Health National Center for Complementary and Integrative Health awarded New York University $785,637 under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) from June 2021 through May 2025. This Cooperative Agreement will support the development and pilot testing of telephone-delivered and video-based Mindfulness-Based Cognitive Therapy (MBCT) protocols for patients with migraine headaches and depressive symptoms. Specifically, the...

Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Viewmind Inc. a Project Grant of $495,731 under the Aging Research program (CFDA 93.866) to evaluate the company's digital health technology platform for early detection of Alzheimer's disease in individuals with mild cognitive impairment (MCI). The award, initiated September 20, 2025, with completion targeted for September 19, 2027, funds validation research on Viewmind's ocular digital phenotyping system, which...